Literature DB >> 9597938

Subtotal adrenalectomy by the posterior retroperitoneoscopic approach.

M K Walz1, K Peitgen, B Saller, R M Giebler, S Lederbogen, K Nimtz, K Mann, F W Eigler.   

Abstract

The retroperitoneoscopic approach offers an established operative procedure for primary adrenal gland tumors. It allows a detailed view of the adrenal gland and its surrounding region. Therefore clear differentiation between normal and neoplastic adrenal tissue is sometimes possible, permitting a planned, unilateral, subtotal resection of the gland. Between July 1994 and August 1997 primary benign adrenal gland tumors (11 Conn adenomas, 4 phenochromocytomas, 4 Cushing adenomas, 3 hormonally inactive tumors; 2.4 +/- 1.2 cm in size; 8 on the right, 14 on the left) were removed from 22 patients by the posterior retroperitoneoscopic approach maintaining tumor-free portions of the ipsilateral adrenal gland. Two patients suffered from bilateral pheochromocytomas associated with multiple endocrine neoplasia (MEN-IIa) syndrome and had previously undergone complete adrenalectomy of the contralateral gland. Following subtotal resection the operating time and blood loss did not differ significantly (p > 0.05) from that seen with complete extirpation (46 patients operated during the same period). All patients with Conn adenomas and pheochromocytomas were biochemically and clinically cured (follow-up 11 months; range 1-31 months). The four patients with Cushing adenoma currently require decreasing cortisol substitution. In the two MEN-II patients adrenal gland cortical function could be maintained; one patient is on low-dose steroid supplementation and the other on none. No local recurrence of tumors has been observed. In selected cases the retroperitoneoscopically performed subtotal adrenal gland resection is a safe procedure that can potentially maintain the function of the adrenal gland cortex.

Entities:  

Mesh:

Year:  1998        PMID: 9597938     DOI: 10.1007/s002689900444

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  18 in total

1.  Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Beate Meier; Kurt W Schmid; Hartmut P H Neumann; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

Review 2.  Minimal access adrenal surgery.

Authors:  L M Brunt
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

3.  Retroperitoneoscopic adrenalectomy in Conn's syndrome caused by adrenal adenomas or nodular hyperplasia.

Authors:  Martin K Walz; Roland Gwosdz; Stephanie L Levin; Piero F Alesina; Anna-Carinna Suttorp; Klaus A Metz; Frank A Wenger; Stephan Petersenn; Klaus Mann; Kurt W Schmid
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

4.  Retroperitoneal adrenal-sparing surgery for the treatment of Cushing's syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients.

Authors:  Hong-chao He; Jun Dai; Zhou-jun Shen; Yu Zhu; Fu-kang Sun; Yuan Shao; Rong-ming Zhang; Hao-fei Wang; Wen-bin Rui; Shan Zhong
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

5.  Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

Authors:  L Michael Brunt; Terry C Lairmore; Gerard M Doherty; Mary A Quasebarth; Mary DeBenedetti; Jeffrey F Moley
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

Review 6.  [Recurrent operations on the adrenal glands].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

7.  Endoscopic retroperitoneal adrenalectomy: lessons learned from 111 consecutive cases.

Authors:  H J Bonjer; V Sorm; F J Berends; G Kazemier; E W Steyerberg; W W de Herder; H A Bruining
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

Review 8.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

Review 9.  [Indication and performance of endocrine surgery. The significance of molecular genetic examination].

Authors:  P E Goretzki; D Wirowski; K Schwarz; P Pohl; H Böhner; A Starke; B J Lammers
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

10.  Limitations of intraoperative adrenal remnant volume measurement in patients undergoing subtotal adrenalectomy.

Authors:  Michael Brauckhoff; Karsten Stock; Susanne Stock; Kerstin Lorenz; Carsten Sekulla; Katrin Brauckhoff; Phuong Nguyen Thanh; Oliver Gimm; Rolf Peter Spielmann; Henning Dralle
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.